Clinical Trial Update: Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on modulators of glutamatergic neurotransmission for Tourette syndrome; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Snippet

Sponsor: Johns Hopkins University | Conditions: Tourette Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2014-07-01